Medicom Innovation Partner as-医療機器分野:企業M&A・提携分析

◆英語タイトル:Medicom Innovation Partner as - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010963
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medicom Innovation Partner a/s (Medicom), formerly Bang & Olufsen Medicom, a subsidiary of Phillips-Medisize Corp, is a medical device company that develops electronic-based drug delivery and connected health systems. The company offers services such as device strategy and direction, device feasibility and concept, device development, and pilot and low-volume production services. Its device feasibility and concept services provide fast forwarding services for device strategy into design concepts and prototypes. Medicom’s target therapy areas include injectables, inhalables and oral therapies. The company invests in technologies, competencies and processes in the areas of drug delivery devices and connected services. It has its presence in China, Denmark and the UK. Medicom is headquartered in Struer, Denmark.

Medicom Innovation Partner as – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medicom Innovation Partner a/s, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medicom Innovation Partner a/s, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medicom Innovation Partner a/s, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medicom Innovation Partner a/s, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Medicom Innovation Partner a/s, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Medicom Innovation Partner a/s, Medical Equipment, Deal Details 10
Private Equity 10
Maj Invest Equity Acquires Remaining 35% Stake in Bang & Olufsen Medicom 10
Partnerships 11
Bang & Olufsen Medicom Enters into Licensing Agreement with Pharma Company 11
Bang & Olufsen Medicom Enters Into Licensing Agreement With Pharma Company For Electronic Auto-Injector 12
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company for Electronic Drug Delivery System 13
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company 14
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 15
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 16
Bang & Olufsen Medicom Enters into Co-Development Agreement with Pharma Company 17
Bang & Olufsen Medicom Enters Into Co-Development Agreement With Pharma Company For Electronic Auto-Injector 18
Acquisition 19
Phillips-Medisize Acquires Medicom Innovation Partner 19
Medicom Innovation Partner a/s – Key Competitors 20
Medicom Innovation Partner a/s – Key Employees 21
Medicom Innovation Partner a/s – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Medicom Innovation Partner a/s, Medical Equipment, Key Facts 2
Medicom Innovation Partner a/s, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Medicom Innovation Partner a/s, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Medicom Innovation Partner a/s, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Medicom Innovation Partner a/s, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Medicom Innovation Partner a/s, Deals By Market, 2011 to YTD 2017 8
Medicom Innovation Partner a/s, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Maj Invest Equity Acquires Remaining 35% Stake in Bang & Olufsen Medicom 10
Bang & Olufsen Medicom Enters into Licensing Agreement with Pharma Company 11
Bang & Olufsen Medicom Enters Into Licensing Agreement With Pharma Company For Electronic Auto-Injector 12
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company for Electronic Drug Delivery System 13
Medicom Innovation Partner Enters into Co-Development Agreement with A Pharma Company 14
Bang & Olufsen Medicom Enters into Co-Development Agreement with Ascendis Pharma 15
Bang & Olufsen Medicom Enters into Co-Development Agreement with Boehringer Ingelheim 16
Bang & Olufsen Medicom Enters into Co-Development Agreement with Pharma Company 17
Bang & Olufsen Medicom Enters Into Co-Development Agreement With Pharma Company For Electronic Auto-Injector 18
Phillips-Medisize Acquires Medicom Innovation Partner 19
Medicom Innovation Partner a/s, Key Competitors 20
Medicom Innovation Partner a/s, Key Employees 21
Medicom Innovation Partner a/s, Other Locations 22
Medicom Innovation Partner a/s, Subsidiaries 22

★海外企業調査レポート[Medicom Innovation Partner as-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pacific Gas and Electric Co-エネルギー分野:企業M&A・提携分析
    Summary Pacific Gas and Electric Company (PGEC), a subsidiary of PG&E Corporation, is an energy utility, offering electricity and natural gas to its customers. The company carries out generation, transmission and distribution of electricity. PGEC serves residential, commercial, industrial and agricu …
  • Carraro Spa:企業の戦略・SWOT・財務情報
    Carraro Spa - Strategy, SWOT and Corporate Finance Report Summary Carraro Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Genentech Inc:企業の戦略的SWOT分析
    Genentech Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Toll Holdings Ltd:企業の戦略的SWOT分析
    Toll Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Autoliv, Inc.:企業の戦略・SWOT・財務分析
    Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report Summary Autoliv, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • OPKO Health Inc (OPK):製薬・医療:M&Aディール及び事業提携情報
    Summary OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vac …
  • Pioneer Natural Resources Company:企業の戦略・SWOT・財務情報
    Pioneer Natural Resources Company - Strategy, SWOT and Corporate Finance Report Summary Pioneer Natural Resources Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Bioceptive Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bioceptive Inc (Bioceptive) is a medical device company that provides medical devices for a variety of gynaecological procedures. The company offers products such as intrauterine devices, intuitive IUD insertion systems and IUD inserters, among others. Its intrauterine devices offer less tra …
  • Cyclacel Pharmaceuticals Inc (CYCC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cyclacel Pharmaceuticals Inc (Cyclacel) is a biopharmaceutical company that develops oral therapies. The company develops small molecule drugs that target various phases of cell cycle control for the treatment of cancer and other serious diseases. Its products include sapacitabine, selicicli …
  • QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them f …
  • National Industrialization Co (2060):企業の財務・戦略的SWOT分析
    National Industrialization Co (2060) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Fingrid Oyj:企業の発電所・SWOT分析2018
    Fingrid Oyj - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Etihad Airways:企業のM&A・事業提携・投資動向
    Etihad Airways - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Etihad Airways Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Irving Oil Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Irving Oil Ltd (Irving Oil) is an oil refining and marketing company that processes, transports, refines and distributes oil and natural gas. The company supplies heavy duty diesel and gasoline engine oils, hydraulic fluids and greases, diesel, heating oil, jet fuel, asphalt products and bun …
  • Ascentage Pharma Group Corp Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Ascentage Pharma Group Corp Ltd (Ascentage Pharma) is a biopharmaceutical company that discovers and develops targeted small-molecule therapeutics for the treatment of cancers, hepatitis B and age-related diseases. The company’s pipeline product includes apoptosis compounds and kinase inhibi …
  • ImaBiotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary ImaBiotech SAS (ImaBiotech) is a contract research organization that provides mass spectrometry imaging services. The organization offers software products such as multimaging and quantinetix. Its service portfolio includes consulting and training, biomarker discovery, pharmaco-kinetics and …
  • Asseco Business Solutions SA (ABS):企業の財務・戦略的SWOT分析
    Asseco Business Solutions SA (ABS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Dunavant Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Dunavant Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dunavant Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Trustco Group Holdings Limited:企業の戦略・SWOT・財務情報
    Trustco Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Trustco Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Klabin SA:企業の戦略・SWOT・財務情報
    Klabin SA - Strategy, SWOT and Corporate Finance Report Summary Klabin SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆